Dysmenorrhea clinical trials

Explore recruiting dysmenorrhea clinical trials.

Recruiting dysmenorrhea studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dysmenorrhea trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase I Study to Assess the Safety and Tolerability of MBF-362 in Healthy Women, and Preliminary Efficacy in Otherwise Healthy Women diagnosed with Primary Dysmenorrhea

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Esketamine As treatment for chronic pain due to endometrioSis: a RCT studY

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection via Hysteroscopy in pelvic pain suggestive of dysmenorrhea: A Prospective, Multicenter, Double-Blind, Randomized Placebo-Controlled Study. HYSTEROXINE Study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of Vitex agnus-castus BNO 1095 (20 mg) in women with primary dysmenorrhea

Sweden, Austria, Poland, Czechia, Hungary, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertility

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, Double-blind, Placebo-controlled, Proof-of-concept Phase II Trial Investigating the Effect of Valproic Acid in Women with Adenomyosis.

Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

Dysmenorrhea trials by city

Dysmenorrhea in Toronto Dysmenorrhea in Vancouver Dysmenorrhea in Montreal Dysmenorrhea in Calgary Dysmenorrhea in Edmonton Dysmenorrhea in Ottawa Dysmenorrhea in Winnipeg Dysmenorrhea in Quebec City Dysmenorrhea in Hamilton Dysmenorrhea in Kitchener Dysmenorrhea in London Dysmenorrhea in Halifax Dysmenorrhea in New York Dysmenorrhea in Los Angeles Dysmenorrhea in Chicago Dysmenorrhea in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease